Medical Marijuana and CBD for Insomnia: Can Cannabis Treat Sleep Disorders? Can CBD and THC Help with Sleep?

Insomnia has ceased to be a niche complaint. According to data cited by the National Health Fund and the Polish Sleep Research Society, one in three adult Poles complains of episodes of difficulty falling asleep, and about 10% meet the criteria for chronic insomnia (WHO ECDD, 2018). In this situation, interest in cannabinoids is growing: medical marijuana prescribed on Rpw and CBD supplements available over the counter. This article organizes scientific evidence, describes sleep physiology, the mechanisms of action of THC and CBD, dosing, and interactions with sleeping medications. We also indicate when a medical consultation is necessary. The text is not medical advice but a review of current knowledge.

Do CBD and THC help with sleep, a brief answer

CBD primarily helps with falling asleep through its anxiolytic action, as confirmed by a retrospective analysis of 72 patients, in which sleep quality improved in 66.7% of individuals in the first month of therapy with doses of 25 to 175 mg per day (Shannon et al., 2019). THC acts short-term, while long-term it disrupts sleep phases.

This is not a marketing statement. Babson, Sottile, and Morabito in their 2017 review describe two different profiles (Babson et al., 2017). Small doses of THC in single exposures can shorten sleep latency and prolong slow-wave sleep. However, regular use reduces REM sleep and leads to tolerance. CBD has the opposite profile: its effect develops gradually but is more stable. Most importantly: neither CBD nor THC will replace the fundamentals of sleep hygiene and CBT-I therapy, which remains the gold standard for treating chronic insomnia.

Quote capsule: CBD affects sleep indirectly by reducing anxiety and arousal of the nervous system. In Shannon's 2019 study, sleep quality improved in 66.7% of 72 patients after the first month of doses of 25 to 175 mg, although the effect fluctuated over time. THC acts faster but chronically shortens REM phase, according to Babson's 2017 review.

Why has insomnia become a public health issue?

Insomnia affects about 30 to 50% of adult Poles in the form of episodic symptoms, and about 10% in the form of chronic insomnia lasting more than 3 months, according to estimates cited by the National Health Fund and the Polish Sleep Research Society. The scale of the problem is increasing with professional pressure and exposure to screens.

How do Poles sleep in 2026

Data from NFZ reports in recent years indicate that prescriptions for zolpidem and benzodiazepines remain at a high level of several million packages per year. Primary care physicians are increasingly recognizing sleep disorders as a symptom coexisting with anxiety and depression, rather than a standalone disease. Remote work, lack of evening rituals, afternoon coffee, and blue light from screens contribute to the typical picture of a 21st-century insomnia patient.

Consequences of chronic sleep deprivation

Sleep deprivation increases the risk of hypertension, obesity, type 2 diabetes, and mood disorders. Just one night of sleep shorter than 5 hours raises cortisol levels the next evening, according to studies referenced by WHO. Long-term sleep deficit is considered a risk factor for neurodegenerative diseases, as during deep sleep the brain activates the glymphatic system that removes waste proteins.

In our store, we observe that inquiries about CBD products under the term "for sleep" constitute the second largest segment of purchasing intent, right after "for pain." This aligns with Google trends recorded year over year.

about CBD and sleep

How does sleep physiology work and why do phases matter?

Human sleep is divided into NREM sleep, which comprises 75 to 80% of the night, and REM sleep, which accounts for 20 to 25% of the night, as confirmed by standard sleep medicine textbooks cited by the American Academy of Sleep Medicine. The REM phase is responsible for the consolidation of emotional memory and dreaming. The deep NREM phase serves somatic regeneration.

The architecture of a healthy adult's night

A typical cycle lasts 90 to 110 minutes and repeats 4 to 6 times during the night. The first cycles are richer in deep N3 sleep, while the subsequent ones are richer in REM sleep. Disruption of any phase translates into other symptoms: lack of N3 causes morning fatigue, while lack of REM impairs memory and emotional regulation. This detail is crucial when assessing the effects of THC.

What happens in the brain during falling asleep

Falling asleep requires a decrease in the activity of the arousal system, including the noradrenergic system from the locus coeruleus, and an increase in the activity of the GABAergic inhibitory system. Melatonin secreted from the pineal gland signals "night" to the circadian clock in the suprachiasmatic nucleus. Any substance that acts on these mechanisms, including cannabinoids, indirectly affects the structure of sleep.

How does the endocannabinoid system regulate sleep?

The endocannabinoid system (ECS) regulates sleep through CB1 receptors located in the hypothalamus, brainstem nuclei, and cortex, as described in Babson's 2017 review (Babson et al., 2017). Endogenous anandamide (AEA) rises during the day and promotes falling asleep in the evening. This explains why ECS modulation translates into sleep-wake rhythm.

CB1 and CB2 receptors and sleep

CB1 receptors dominate in the central nervous system and are the main target of THC. CB2 receptors are primarily found in immune system cells and are significant in neuroinflammation associated with chronic insomnia. CBD does not strongly bind to either of these receptors but acts indirectly: it inhibits the breakdown of anandamide, modulates the 5-HT1A receptor, and affects the TRPV1 receptor.

Anandamide, oleamide, and the natural sleep rhythm

Oleamide, an endogenous lipid structurally similar to anandamide, accumulates in the cerebrospinal fluid of sleep-deprived individuals and exhibits sedative effects in animal models, as described in literature referenced by WHO ECDD (WHO ECDD, 2018). This suggests that ECS is not a peripheral addition but an element of sleep self-regulation architecture.

Contrary to the popular simplification "CBD activates CB1", biochemical data show the opposite. CBD is a weak antagonist or allosteric modulator of CB1, and its prosocial effect mainly results from inhibiting the reabsorption of anandamide and influencing the serotonergic system. This is why CBD does not cause drowsiness as abruptly as THC.

Quote capsule: CB1 receptors in the hypothalamus and brainstem participate in the regulation of sleep and wakefulness. Anandamide, a natural endocannabinoid, exhibits diurnal rhythm and promotes falling asleep. THC activates CB1 directly, while CBD modifies ECS indirectly by inhibiting the breakdown of anandamide, as described in Babson's 2017 review.

How does THC affect sleep, the short-term paradox

THC short-term shortens sleep latency and prolongs N3 phase, but chronic use reduces REM sleep and leads to tolerance, as shown in the Babson, Sottile, Morabito review from 2017 covering several studies (Babson et al., 2017). This paradox has crucial clinical significance for patients considering long-term therapy.

Short-term effects of THC

In individuals taking THC occasionally, faster sleep onset, fewer awakenings in the first half of the night, and a greater amount of slow-wave sleep N3 are observed. The mechanism is associated with the activation of CB1 in the cortex and the reticular nucleus of the thalamus. Subjectively, patients describe this as "deep, heavy sleep", although the structure of the night is disrupted.

Long-term consequences

After several weeks of daily THC use, the body develops tolerance to the sleep-inducing effect. Moreover, the reduction of REM phase persists during therapy. Upon cessation, REM rebound occurs: excess REM phase, nightmares, and sleep fragmentation, sometimes lasting 2 to 4 weeks. Bonn-Miller and colleagues showed that individuals using cannabis for self-treatment of insomnia more frequently report sleep problems during attempts at abstinence (Bonn-Miller et al., 2014).

When THC may have clinical significance

Medical marijuana with THC is sometimes considered for patients with insomnia secondary to chronic pain, spasticity in multiple sclerosis, or PTSD. In these indications, the clinical benefit comes not only from the sleep-inducing effect but mainly from the reduction of pain and anxiety that kept the patient awake. In Poland, such therapy requires a prescription Rpw and should be conducted under a doctor's supervision.

regulatory guide

How does CBD affect sleep, the anxiolytic mechanism

CBD improves sleep quality indirectly by acting anxiolytically through the 5-HT1A receptor and inhibiting the breakdown of anandamide, and in Shannon's retrospective analysis from 2019, sleep quality improved in 48 out of 72 patients in the first month, which is 66.7% (Shannon et al., 2019). This distinguishes CBD from classic sleeping medications that act directly on GABA.

Evidence from Clinical Studies

Already Carlini and Cunha in their pioneering study from 1981 found that oral CBD at a dose of 160 mg prolonged sleep time and reduced the number of awakenings in patients with insomnia, although at lower doses of 40 and 80 mg the effect was limited (Carlini and Cunha, 1981). Shannon and Opila-Lehman also described the case of a 10-year-old patient with PTSD, in whom a dose of 12 to 25 mg of CBD per day improved sleep and reduced anxiety over 5 months (Shannon and Opila-Lehman, 2016).

Safety of CBD according to WHO

WHO ECDD in its 2018 review stated that CBD has a favorable safety profile, does not cause addiction, and has no potential for abuse (WHO ECDD, 2018). Iffland and Grotenhermen in their 2017 review confirmed good tolerance of doses up to 1500 mg per day, although interactions with drugs metabolized by CYP3A4 and CYP2C19 were noted (Iffland and Grotenhermen, 2017).

When CBD may not work

CBD struggles with purely behavioral insomnia resulting from poor sleep hygiene, afternoon coffee, or jet lag. It also does not replace treatment for obstructive sleep apnea or restless legs syndrome, where specialized diagnostics are needed. CBD works best when insomnia is linked to anxiety, evening rumination, or chronic stress.

Quote capsule: CBD reduces anxiety by modulating the 5-HT1A receptor and inhibiting the breakdown of anandamide, which indirectly supports falling asleep. In Shannon's 2019 study, 48 out of 72 patients (66.7%) reported improved sleep in the first month at doses of 25 to 175 mg. The pioneering work of Carlini and Cunha in 1981 showed an extension of sleep after 160 mg of CBD.

What is CBN and does it really induce sleep?

CBN, or cannabinol, is a product of THC oxidation present in small amounts in old flower, and the thesis about its strong sedative effect is based on anecdotes, not on rigorous clinical studies, as indicated by reviews referenced by WHO. The myth "CBN is the sleep cannabinoid" requires careful verification.

Where did CBN's reputation as a hypnotic come from

The hypothesis emerged in the 1970s based on observations that old, aged cannabis produced a stronger sleep-inducing effect than fresh. This was linked to higher CBN content resulting from THC degradation. However, later clinical trials did not confirm a significant hypnotic effect of CBN in isolation.

Current state of evidence

Most of the alleged effects of "aged" flower likely result from the synergy of remaining THC and terpenes such as myrcene, rather than from CBN itself. Until solid clinical studies with a placebo group are published, it is better to treat claims of "CBN for sleep" as marketing rather than medical indications.

Some manufacturers offer "sleep oils" with added CBN, suggesting a synergistic effect. Without randomized clinical studies, this is a commercial claim, not a scientific one. It is safer to focus on full-spectrum products with a well-documented CBD profile.

How does CBD compare to sleeping medications?

CBD has a significantly lower potential for addiction than benzodiazepines and Z-drugs, and is also free from the risk of sleep attack typical of zolpidem, but has a much weaker immediate effect, as indicated by the safety profile comparison cited by Iffland and Grotenhermen (Iffland and Grotenhermen, 2017). The choice of therapy depends on the type of insomnia and the duration of symptoms.

Benzodiazepines and Z-drugs

Benzodiazepines such as temazepam, lorazepam, or diazepam act agonistically on the GABA-A receptor and shorten sleep latency in a predictable manner. The price: the risk of psychophysical addiction after a few weeks, tolerance, impairment of episodic memory, and disruption of sleep structure through the reduction of deep sleep. Z-drugs, such as zolpidem or zopiclone, are safer but carry the risk of parasomnias: sleepwalking, eating at night with no recollection.

Melatonin, the circadian clock hormone

Melatonin is not a classic sleeping medication but a regulator of the circadian clock. It works best in insomnia of chronobiological origin: jet lag, shift work, delayed sleep phase. A standard dose of 0.5 to 3 mg taken 1 to 2 hours before sleep is effective in a narrow indication but struggles with anxiety-related insomnia.

Off-label antidepressants

Mirtazapine, trazodone, or doxepin in low doses are often used off-label in insomnia. Their profile includes a strong sleep-inducing effect, but also morning drowsiness, weight gain, and potential metabolic disorders. They require a prescription and psychiatric supervision.

CBD in this family

CBD does not replace benzodiazepines in patients with severe acute insomnia. It works as support in mild and moderate insomnia associated with anxiety, as part of a benzodiazepine tapering strategy under medical supervision, and as a complement to CBT-I. It does not cause morning drowsiness, is well tolerated, and does not disrupt REM structure.

What are the interactions of CBD with sleeping medications?

CBD inhibits cytochrome P450 isoenzymes, including CYP3A4, CYP2C19, and CYP2D6, which may raise the concentration of many medications, including warfarin, clobazam, and some benzodiazepines, as described in the safety review by Iffland and Grotenhermen from 2017 (Iffland and Grotenhermen, 2017). Any combined therapy should be consulted with a physician.

Most clinically significant interactions

Clobazam: CBD increases the concentration of the active metabolite N-desmethylclobazam, which requires a reduction in the dose of clobazam under the supervision of a neurologist. Warfarin: cases of increased INR after the introduction of CBD have been described, so more frequent monitoring of the index is necessary. Benzodiazepines: theoretical potentiation of sedation, although the clinical effect is moderate.

What to do when combining medications

Start with the lowest dose of CBD, monitor symptoms of excessive morning sedation, maintain a 2-hour interval between CBD and other oral medications, and inform your physician about using CBD. Do not abruptly discontinue benzodiazepines, as this risks withdrawal symptoms: seizures, anxiety, rebound insomnia.

In store practice, we often talk to customers taking cardiology and antiplatelet medications. The standard recommendation is: consult the introduction of CBD with a cardiologist, start with 10 mg daily, and keep a symptom diary. This is a simple scheme that minimizes the risk of interactions.

How to dose CBD for insomnia?

For insomnia, CBD is typically dosed from 10 to 40 mg per night, taking the oil sublingually 30 to 60 minutes before sleep or capsules 1 to 2 hours earlier, which corresponds to effective ranges in Shannon's retrospective analysis from 2019 covering doses of 25 to 175 mg per day (Shannon et al., 2019). Dosing starts from the lowest dose.

Dosing scheme, step by step

Week 1: 10 mg CBD 45 minutes before sleep, keeping a sleep diary. Week 2: if the effect is insufficient, increase to 20 mg. Weeks 3 and 4: possible increase to 30 to 40 mg. Doses above 40 mg per night without medical consultation rarely make sense, as most users respond to doses in the range of 15 to 30 mg.

Form and onset of action

Sublingual oil acts in 20 to 60 minutes, capsules in 60 to 120 minutes, vaporized flower in 5 to 15 minutes, but the latter form is rarely applicable in the evening due to its short duration of action of 2 to 4 hours. For sleep-onset insomnia, oil or capsule is best. For insomnia with early awakenings, an extended-release capsule or a small repeat dose of oil at night works well.

Full spectrum vs isolate

Full-spectrum oils contain trace amounts of THC below 0.3% and other cannabinoids and terpenes, utilizing the entourage effect. CBD isolates are pure but clinically weaker in insomnia. Most practitioners recommend full spectrum unless there are contraindications such as drug testing at work.

CBD or melatonin, which to choose?

Melatonin works well in chronobiological insomnia such as jet lag and shift work, while CBD has an advantage in anxiety and stress-related insomnia, as indicated by the comparison of their mechanisms of action referenced by WHO (WHO ECDD, 2018). The combination of both substances is sometimes used in complex products.

Application profiles

Choose melatonin when: you are changing time zones, working shifts, have delayed sleep phase syndrome, or are over 55 with a natural decline in melatonin production. Choose CBD when: insomnia is associated with anxiety, evening rumination, chronic stress, pain, or when melatonin has not worked.

Combination of CBD and melatonin

Some supplements combine 1 to 3 mg of melatonin with 10 to 25 mg of CBD. The logic is complementary: melatonin helps "turn on the night", CBD calms the mind. However, there is a lack of large RCT studies on such combinations, so dosing should be consulted with a doctor. Do not combine high doses of melatonin with anticoagulants without consultation.

Which terpenes promote sleep?

Myrcene, linalool, and beta-caryophyllene are the terpenes most often mentioned in the context of sleep-inducing effects, although the evidence comes mainly from animal models and aromatherapy studies, as referenced in the review literature on the entourage effect. Full-spectrum cannabis extracts contain these compounds in natural proportions.

Myrcene, the most commonly cited "sleep terpene"

Myrcene is found in mango, hops, and many strains of indica cannabis. In animal models, it exhibits sedative and muscle relaxant effects. In cannabis, often above 0.5% dry weight, myrcene is associated with the "couch lock" effect, although evidence in humans is limited.

Linalool and beta-caryophyllene

Linalool is the dominant terpene in lavender, known for its anxiolytic action confirmed in clinical aromatherapy. Beta-caryophyllene is the only terpene active against the CB2 receptor, has anti-inflammatory effects, and may indirectly reduce nighttime arousal related to pain.

Practical significance for product selection

Full-spectrum CBD oils contain a mixture of terpenes characteristic of a given strain. A manufacturer indicating the terpene profile in the Certificate of Analysis (COA) gives consumers greater control. In the context of sleep, it is worth looking for products containing myrcene and linalool.

Sleep hygiene and CBT-I, the foundation of treatment

CBT-I, or cognitive behavioral therapy for insomnia, is the first-line treatment for chronic insomnia, with effects comparable to sleeping medications in the short term and superior in the long term, as confirmed by the guidelines of the American College of Physicians cited by WHO. CBD and cannabinoids are an addition, not an alternative.

Five sleep hygiene principles with the strongest evidence

Consistent wake-up times seven days a week, elimination of coffee and energy drinks after 2 PM, exposure to daylight in the morning within the first hour after waking, limiting screens an hour before sleep, and a cool, dark bedroom with a temperature of 18 to 20 degrees Celsius. These five interventions have effects comparable to medications in some patients with mild insomnia.

What does CBT-I consist of

CBT-I combines techniques: stimulus control (bed only for sleep and sex), sleep restriction (temporarily shortening time in bed), relaxation techniques, cognitive restructuring of thoughts about sleep, and education. In Poland, the availability of CBT-I therapists is limited, but the number of digital applications with documented effectiveness is increasing. Consultation with a psychologist or sleep physician is the first step.

about healthy sleep habits

When to see a doctor for insomnia?

Insomnia lasting longer than 3 months, occurring at least 3 nights a week and causing deterioration in daytime functioning meets the criteria for chronic insomnia according to the ICSD-3 classification and requires medical consultation, according to guidelines cited by WHO (WHO ECDD, 2018). Do not attempt to treat such symptoms solely with supplements.

Red flags requiring urgent diagnostics

Loud snoring with pauses in breathing at night may indicate obstructive sleep apnea (OSA), which increases cardiovascular risk and requires polysomnography. Daytime sleepiness despite sufficient hours of sleep, restless legs in the evening, parasomnias, and recurring nightmares are other signals for a specialist.

What tests may a doctor order

Diagnostics include a structured interview, questionnaires such as ISI (Insomnia Severity Index) and PSQI, a sleep diary kept for 1 to 2 weeks, and if necessary, polysomnography in a sleep lab. Blood tests check thyroid function, iron and ferritin deficiency (associated with restless legs syndrome), and general health markers.

Polish legal context of medical marijuana and CBD

In Poland, medical marijuana with THC is available by prescription Rpw based on the amendment to the Act on Counteracting Drug Addiction from July 7, 2017, while CBD derived from hemp with THC below 0.3% remains legal and available over the counter as food or cosmetics, as confirmed by GIS interpretations. This distinction has practical significance.

Prescription Rpw, how to obtain it

A prescription Rpw for medical marijuana requires consultation with a physician authorized to issue such prescriptions. Indications most often include chronic pain resistant to other therapies, spasticity in MS, certain forms of epilepsy, nausea after chemotherapy, and selected psychiatric cases. Insomnia as a standalone indication is rarely accepted in Poland, more often as secondary to another chronic disease.

Status of CBD in 2026

CBD derived from hemp Cannabis sativa L. containing less than 0.3% THC is legal in Poland. It can be sold as a cosmetic, dietary supplement, or in some forms as food (after meeting the requirements of the EU Novel Food regulation). The manufacturer should provide a Certificate of Analysis (COA) confirming cannabinoid content and absence of heavy metals.

Consumer caution

The CBD market in Poland contains products of very varying quality. Choose oils with a COA available for review, indicating CBD content on the label in mg, known origin of the extract, and clear information about THC content. Avoid products without analyses or with therapeutic claims contrary to the law.

consumer guide

Recommended products supporting sleep quality

When selecting a CBD product for sleep, pay attention to the concentration allowing comfortable dosing of 10 to 40 mg per night, sublingual form or capsules, full spectrum with natural terpenes, and available COA. Below are examples from the u Bucha store assortment, selected for typical needs of users seeking support for sleep quality.

• SOOL CBD 5% (10 ml), 76 PLN: full-spectrum oil for those starting their journey with CBD, one drop is about 2.5 mg of CBD, easy dosing from 10 to 20 mg per night.
• SOOL CBD 10% (10 ml), 99 PLN: a more concentrated oil for users requiring doses of 20 to 40 mg, one drop is about 5 mg of CBD, an economical choice for regular therapy.
• Cannova CBG 15% (10 ml), 240 PLN: oil with cannabigerol (CBG), a cannabinoid with modulating properties, used as a complement to CBD in complex protocols, for those testing the entourage effect.
• Mars CBD 9% Hemp Buch, 59 PLN: full-spectrum CBD flower for vaporization in the afternoon, terpene profile rich in myrcene, for those preferring inhalation as a form of application.

The above products are supplements supporting comfort during the day and evening, do not replace treatment for chronic insomnia or consultation with a physician. The decision to introduce CBD in the presence of coexisting diseases or pharmacotherapy should be agreed upon with the attending physician.

Frequently Asked Questions (FAQ)

Does CBD help with insomnia?

CBD helps with anxiety and stress-related insomnia, acting indirectly through the 5-HT1A receptor and inhibiting the breakdown of anandamide. In Shannon's retrospective analysis of 72 patients from 2019, sleep quality improved in 66.7% of subjects in the first month of therapy with doses of 25 to 175 mg per day (Shannon et al., 2019).

What dose of CBD for sleep is effective?

The typical effective range is 10 to 40 mg of CBD per night, titrated from the lowest dose over 2 to 4 weeks. In the study by Carlini and Cunha from 1981, a significant sleep effect appeared only at 160 mg, but contemporary practices indicate that most patients respond in the range of 15 to 30 mg daily (Carlini and Cunha, 1981).

Does THC help you fall asleep?

THC short-term shortens sleep latency and prolongs slow-wave sleep, but with regular use, it reduces REM phase and causes tolerance, according to the review by Babson, Sottile, Morabito from 2017 (Babson et al., 2017). In Poland, medical marijuana with THC is available only by prescription Rpw, and insomnia is rarely a standalone indication.

When to take CBD oil for sleep?

Sublingual CBD oil is taken 30 to 60 minutes before planned sleep, held under the tongue for 60 to 90 seconds, maximizing absorption through the mucous membrane. Capsules are taken 60 to 120 minutes earlier, as they go through first-pass metabolism in the liver.

Can CBD be combined with melatonin?

CBD and melatonin have complementary mechanisms of action, so they are sometimes combined in complex products. There is a lack of large RCT studies confirming the superiority of such a combination over single substances. Standardly, 1 to 3 mg of melatonin is combined with 10 to 25 mg of CBD, but dosing should be discussed with a physician when on ongoing pharmacotherapy.

Does CBD cause addiction?

WHO ECDD in its 2018 review stated that CBD does not show addictive potential or potential for abuse, unlike THC and benzodiazepines (WHO ECDD, 2018). The safety profile has also been confirmed in the review by Iffland and Grotenhermen from 2017 when using doses up to 1500 mg per day.

Does CBD disrupt REM phase like THC?

CBD does not show a significant impact on the REM phase comparable to THC. In Babson's 2017 review, CBD is described as neutral or mildly beneficial for sleep architecture, while THC reduces REM with regular use (Babson et al., 2017). This is a key difference for patients planning long-term therapy.

What drugs interact with CBD?

CBD inhibits cytochrome P450 isoenzymes, including CYP3A4, CYP2C19, and CYP2D6, which raises the concentration of warfarin, clobazam, some benzodiazepines, statins, and antidepressants. Iffland and Grotenhermen in their 2017 review recommend monitoring the concentrations of drugs with a narrow therapeutic window (Iffland and Grotenhermen, 2017). Consult the introduction of CBD with your attending physician.

Can CBD help a child with insomnia?

Shannon and Opila-Lehman described the case of a 10-year-old patient with PTSD, in whom 12 to 25 mg of CBD daily improved sleep and reduced anxiety over 5 months (Shannon and Opila-Lehman, 2016). The use of CBD in children should occur only under the supervision of a pediatrician or neurologist, never based on a parent's independent decision.

Does CBD replace CBT-I therapy?

CBD does not replace cognitive behavioral therapy for insomnia (CBT-I), which remains the first-line treatment for chronic insomnia according to the guidelines of the American College of Physicians cited by WHO. CBD may be considered as support reducing evening anxiety and facilitating the implementation of behavioral techniques, but not as monotherapy.

Summary and conclusions

Cannabinoids are a real option supporting sleep, but with significant caveats. CBD shows a beneficial profile in anxiety and stress-related insomnia, acting indirectly through modulation of the serotonergic and endocannabinoid systems, is well tolerated, and does not cause addiction. THC provides a quick sleep effect but chronically disrupts sleep architecture and requires a prescription Rpw in Poland. CBD dosing for sleep typically falls within the range of 10 to 40 mg per night, administered sublingually 30 to 60 minutes before sleep.

Remember that no substance will replace sleep hygiene and CBT-I therapy, which remains the gold standard. Insomnia lasting longer than 3 months requires medical consultation, especially when obstructive sleep apnea, anxiety-depressive disorders, or pharmacotherapy interacting with CBD are suspected. A conscious consumer chooses products with a COA certificate, starts with the lowest dose, keeps a sleep diary, and consults any therapy changes with a specialist.

Author: Michał Waluk, editorial team at u Bucha. The text is prepared based on current scientific literature and does not constitute medical advice. In case of chronic sleep disorders, consult a physician.